Molecular Diagnostics Supporting a ≥35% Diffuse Peritubular Capillaritis Extent Threshold for Diagnosis of AMR—A Retrospective Dual Center Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262210945 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Michael Eder und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Graft Rejection, Kidney Transplantation, Capillaries, Pathology, Molecular. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peritubular capillaritis (ptc) is a hallmark lesion of antibody-mediated rejection (AMR), but the grading of its extent is historically based on arbitrary defined cut-offs. Molecular AMR diagnosis via intragraft gene expression measurements may provide evidence to challenge established ptc categories. We retrospectively included 38 renal allograft biopsies from clinical routine, performed because of suspicion of AMR. Biopsies were re-assessed by an experienced nephropathologist and intragraft gene expression was measured using the NanoString nCounter® platform. Ptc categories were correlated with AMR gene expression to identify a ptc extent cut-off with optimal prediction of molecular diagnosis of AMR [gene expression levels above first quartile (AMRQ>1)]. Finally, an independent validation cohort (n = 25, Erasmus MC, Rotterdam, The Netherlands) was included to reproduce the results. Re-assessment of biopsies revealed AMR in 26/68.4%, mixed rejection in 5/13.2%, and T-cell-mediated rejection in 3/7.9%. Biopsies with diffuse ptc had significantly higher AMR gene expression compared to biopsies with focal ptc and biopsies with no ptc (64.0/53.3–84.0 vs. 31.5/27.0–49.5, p = 0.023 and 27.0/14.3–31.8, p = 0.003, median/IQR). Sensitivity analysis revealed that a ≥35% ptc cut-off resulted in higher AUCs for predicting AMRQ>1 compared to ptc50% (AUC 0.78, 95% CI: 0.63–0.93, p = 0.009 versus AUC: 0.74, CI: 0.56–0.90, p = 0.03). In the validation cohort, only the ptc35–, but not the ptc50%, cut-off significantly predicted AMRQ>1 (AUC 0.75, 95% CI: 0.54–0.96 p = 0.04 vs. AUC 0.69, CI: 0.46–0.93, p = 0.13). Using intragraft gene expression measurement, we identified a new ptc extent threshold with better prediction of molecular AMR. The newly proposed cut-off of ≥35% could potentially improve diagnostic evaluation and prognostication in cases with suspected or diagnosed AMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
- University Hospital RWTH Aachen, Department of Nephrology, 52074 Aachen, Germany.
- Department of Pathology and Clinical Bioinformatics, Erasmus MC Transplant Institute, 3015 GD Rotterdam, The Netherlands.
- Laboratory for Pathology (PAL), 3318 AL Dordrecht, The Netherlands.
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
- Department of Medicine III, Nephrology, Hypertension, Transplantation and Rheumatology, Ordensklinikum Linz-Elisabethinen, 4010 Linz, Austria.
ORCID-Profile: Michael Eder, Michael Mengel, Daniel Cejka, Benjamin Adam, Nicolas Kozakowski
Zitieren
APA
Eder, M., Clahsen-van Groningen, M. C., Mengel, M., Omic, H., Cejka, D., Adam, B., Kozakowski, N., & Kikić, Ž. (2025). Molecular Diagnostics Supporting a ≥35% Diffuse Peritubular Capillaritis Extent Threshold for Diagnosis of AMR—A Retrospective Dual Center Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210945
Vancouver
Eder M, Clahsen-van Groningen MC, Mengel M, Omic H, Cejka D, Adam B, et al. Molecular Diagnostics Supporting a ≥35% Diffuse Peritubular Capillaritis Extent Threshold for Diagnosis of AMR—A Retrospective Dual Center Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210945
BibTeX
@article{Eder2025,
author = {Eder, Michael and Clahsen-van Groningen, Marian C and Mengel, Michael and Omic, Haris and Cejka, Daniel and Adam, Benjamin and Kozakowski, Nicolas and Kikić, Željko},
title = {Molecular Diagnostics Supporting a ≥35% Diffuse Peritubular Capillaritis Extent Threshold for Diagnosis of AMR—A Retrospective Dual Center Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262210945}
}
EUVIMED